Effect of low-dose aspirin administration on long-term survival of cirrhotic patients after splenectomy: A retrospective single-center study

Table 1 General clinical characteristics of the patients

Clinical characteristic	Median (range)/n (%)
Demographic feature
Age (yr)	45 (20-67)
Gender (male:female)	194:70
Underlying disease
HBV	248 (93.94)
HCV	14 (5.30)
HBV and HCV	2 (0.76)
Coexisting condition
Drinking	33 (12.50)
Smoking	65 (24.62)
Hypertension	58 (21.97)
Diabetes	21 (7.95)
Laboratory results
Leucocytes (109/L)	2.66 (0.60-59.00)
Platelet count (<30 × 109/L)	71 (26.89)
Hemoglobin (g/L)	97 (18-175)
ALT (>40 U/L)	91 (34.47)
AST (>40 U/L)	124 (46.97)
Albumin (<35 g/L)	125 (47.35)
Total bilirubin (>17 μmol/L)	184 (69.70)
Creatinine (μmol/L)	66 (15-188)
PT (>17 s)	79 (29.92)
APTT (>45 s)	77 (29.17)
INR (>1.2)	179 (67.80)
Fibrinogen (g/L)	1.89 (0.60-5.36)
AFP (mg/L)	10.83 (0.76-140.90)
Child-Pugh score
Child A	80 (30.30)
Child B	165 (62.50)
Child C	19 (7.20)
Intraoperative and postoperative features
Intraoperative blood loss (mL)	425 (50-2000)
Spleen volume (mm3)	1410 (156-4896)
Spleen size (mm)	158 (12-230)
Surgical method
Laparoscopic surgery	36 (13.64)
Open laparotomy	228 (86.36)
Portal vein thrombosis	47 (17.80)
Postoperative aspirin	59 (22.35)
Length of hospital stay	27 (11-125)

HBV: Hepatitis B virus; HCV: Hepatitis C virus; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; PT: Prothrombin time; APTT: Activated partial thromboplatin time; INR: International normalized ratio; AFP: Alpha fetoprotein; ICU: Intensive care unit.